RESEARCH ARTICLE


Relation of Plasma Obestatin Levels with BMI and HOMA-IR in Syrian Obese Patients with Type 2 Diabetes



Hiba Alhalbouni1, *, Youns Kabalan2, Faizeh Alquobaili1
1 Department of Biochemistry and Microbiology, Faculty of Pharmacy, Damascus University, Damascus, Syria
2 Department of Endocrinology, Faculty of Medicine, Damascus University, Damascus, Syria


Article Metrics

CrossRef Citations:
0
Total Statistics:

Full-Text HTML Views: 581
Abstract HTML Views: 509
PDF Downloads: 160
ePub Downloads: 139
Total Views/Downloads: 1389
Unique Statistics:

Full-Text HTML Views: 401
Abstract HTML Views: 222
PDF Downloads: 141
ePub Downloads: 119
Total Views/Downloads: 883



Creative Commons License
© 2017 Alhalbouni et al.

open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

* Address correspondence to this author at the Department of Biochemistry and Microbiology, Faculty of Pharmacy, Damascus University, Damascus, Syria, Tel: +963937276440; E-mail: Dr.hiba.alhalbouni@hotmail.com


Abstract

Background:

Obestatin is a novel hormone derived from preproghrelin, which was reported to inhibit appetite and gastric motility.

Study Aim:

This study aimed to investigate plasma obestatin levels in obese patients with T2D patients, which had not been studied clearly in last researches.

Methods:

23 normal weight subjects, 35 obese subjects and 31 obese patients with T2D participated in the study, the body mass index was calculated. Fasting glucose and insulin levels were measured and the homeostasis model assessment of insulin resistance (HOMA-IR) was determined. Plasma obestatin levels were measured with enzyme-linked immune sorbent assay (ELISA). The relationship between plasma obestatin levels and biochemical parameters was also analyzed.

Results:

Fasting obestatin was significantly lower in obese patients with T2D, comparing to control subjects (mean=6.35 vs12.38ng/ml) and to the non-patients obese group (mean=6.35 vs 7.76 ng/ml). Obestatin levels correlated significantly and negatively with BMI (R=-0. 451; P=0. 01), basal insulin levels (R=-0.737, P<0.0001) and HOMA-IR (R=-0. 764, P<0.0001) in diabetic patients.

Conclusion:

Our results suggest that obestatin may contribute to body weight regulation, and insulin sensitivity could be affected by obestatin levels.

Keywords: Obestatin, BMI, HOMA-IR, Type 2 diabetes mellitus, Homeostasis, Insulin.